Trials / Sponsors / Karen-Lise Garm Spindler
Karen-Lise Garm Spindler
Academic / Other · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | The ctDNA-RECIST Trial Part One Gastrointestinal Neoplasm | Phase 2 | 2025-01-15 |
| Recruiting | OPTIMIzation of Treatment SElection and Follow up in Oligometastatic Colorectal Cancer Colorectal Cancer, Metastatic Cancer | Phase 2 | 2021-10-25 |
| Active Not Recruiting | Bone-sparing Chemoradiotherapy for Anal Cancer - DACG-II Anal Cancer, Radiotherapy Side Effect | N/A | 2021-08-23 |
| Unknown | IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative Colorectal Cancer, Circulating Tumor DNA, Adjuvant Chemotherapy | Phase 2 | 2018-10-01 |
| Completed | OPTImal PALliative Anti-epidermal Growth Factor Receptor Treatment in Metastatic Colorectal Cancer - Colorectal Cancer Metastatic, Circulating Tumor DNA, KRAS Gene Mutation | — | 2018-06-01 |